Norges Bank G1 Therapeutics, Inc. Transaction History

Norges Bank

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$1.22 - $2.67 $275,354 - $602,619	-225,700 Closed	0 $0
Q4 2022 Feb 14, 2023	BUY	$5.19 - $13.5 $1.17 Million - $3.05 Million	225,700 New	225,700 $1.23 Million
Q3 2022 Nov 13, 2023	BUY	$5.17 - $16.99 $1.17 Million - $3.83 Million	225,700 New	225,700 $2.82 Million
Q2 2018 Jul 23, 2018	SELL	$35.06 - $51.17 $1.4 Million - $2.05 Million	-40,000 Closed	0 $0
Q1 2018 May 15, 2019	BUY	$19.05 - $41.76 $762,000 - $1.67 Million	40,000 New	40,000 $1.48 Million
Q1 2018 May 09, 2018	SELL	$19.05 - $41.76 $762,000 - $1.67 Million	-40,000 Closed	0 $0
Q4 2017 Mar 05, 2018	BUY	$19.01 - $26.2 $760,400 - $1.05 Million	40,000 New	40,000 $794,000
Q4 2017 Feb 09, 2018	SELL	$19.01 - $26.2 $760,400 - $1.05 Million	-40,000 Closed	0 $0
Q3 2017 Nov 13, 2018	BUY	$12.53 - $27.12 $501,200 - $1.08 Million	40,000 New	40,000 $996,000
Q3 2017 Nov 07, 2017	SELL	$12.53 - $27.12 $501,200 - $1.08 Million	-40,000 Closed	0 $0
Q2 2017 Jul 24, 2018	BUY	N/A	40,000	40,000 $698,000

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

Stay updated on Norges Bank with notifications on news.